This content is from: Portfolio Healthcare Dealmaking Slowed for the Fifth Consecutive Quarter According to PitchBook, steadily decreasing valuations in healthcare may force PE firms to accept that a ‘wait and see’ approach is no longer viable. By Hannah Zhang May 10, 2023
This content is from: Premium Hedge-Fund-Backed Acelyrin Makes a Strong IPO Debut In a brutal IPO environment, the biopharma company soared 30 percent in its first day of trading. By Gary Perkinson May 09, 2023
This content is from: Corner Office Marcus Loss Overshadows Positives at Goldman Sachs The asset and wealth management division continued to grow its alternative investments business in the first quarter, reaching $268 billion. By Michael Thrasher April 18, 2023
This content is from: Portfolio Allocators on Greenwashing: ‘We Are the Ones Writing the Check’ Asset owners shared their approaches to sustainable investing at a CFA Institute conference on Thursday. By Alicia McElhaney April 21, 2023
This content is from: Corner Office How Aflac’s New Investment Chief Is Handling Volatility, Rising Rates, and a Banking Crisis “You don’t wait to see storm clouds to start weather proofing your house,” says Brad Dyslin. By Alicia McElhaney March 23, 2023
This content is from: Portfolio Life Insurers Could Face Liquidity Crunch Next Rising interest rates coupled with “uncharted lapse territory” could put financial pressure on some life insurance companies, a Barings report says. By Michael Thrasher April 17, 2023
